Hashemi Zahra Sadat, Moghadam Mehdi Forouzandeh, Farokhimanesh Samila, Rajabibazl Masoumeh, Sadroddiny Esmaeil
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Iran J Basic Med Sci. 2018 Apr;21(4):427-433. doi: 10.22038/IJBMS.2018.26614.6522.
Various studies have been conducted to reduce the metastatic behavior of cancerous cells. In this regard, ectopic expression of anti-metastatic microRNAs by miR-mimic and miR-restoration-based therapies could bring new insights to the field. In the present study, the consequences of co-transfecting breast cancer cell lines with miR-193b and miR-31 were investigated via invasion and migration assays.
Double stranded oligonucleotide of mature miR-193b-3p and miR-31-5p were cloned into pcDNA 6.2gw/EmGFP plasmid. The resulting plasmids were used for transfection. Real time-PCR was performed to assess the expression of miR-193b and miR-31 as well as Ras homolog gene family member A (RhoA) and urokinase-type plasminogen activator (uPA) as miR targets. Scratch, Transwell migration and Matrigel invasion assays were carried out to assess the extent of migration and invasion of cell lines.
The most significant increase in expression of miRs belonged to the single transfection of mimic-miRs in MDA-MB231. Although the co-transfection was not as successful as single transfection in miR expression, it was significantly more effective in inhibition of the cells invasive potential.
Although the miR-restoration therapy based on co-transfection of two miRs could be less effective in expression of each miRNA, the resulting decrease in metastatic behavior of the cells is more significant due to collective effect of co-transfection to decrease target gene expression. Our results revealed that employing this sort of combinatorial strategies could lead to more efficient reduction in metastatic behavior. It seems that using this strategy would bring about more successful therapeutic outcomes.
已开展了多项研究以降低癌细胞的转移行为。在这方面,基于miR模拟物和miR恢复疗法的抗转移微小RNA的异位表达可为该领域带来新的见解。在本研究中,通过侵袭和迁移试验研究了miR-193b和miR-31共转染乳腺癌细胞系的后果。
将成熟miR-193b-3p和miR-31-5p的双链寡核苷酸克隆到pcDNA 6.2gw/EmGFP质粒中。所得质粒用于转染。进行实时定量聚合酶链反应以评估miR-193b和miR-31以及作为miR靶标的Ras同源基因家族成员A(RhoA)和尿激酶型纤溶酶原激活剂(uPA)的表达。进行划痕试验、Transwell迁移试验和基质胶侵袭试验以评估细胞系的迁移和侵袭程度。
miR表达的最显著增加属于MDA-MB231中模拟miR的单次转染。尽管共转染在miR表达方面不如单次转染成功,但在抑制细胞侵袭潜力方面显著更有效。
尽管基于两种miR共转染的miR恢复疗法在每种微小RNA的表达方面可能效果较差,但由于共转染降低靶基因表达的集体效应,细胞转移行为的降低更为显著。我们的结果表明,采用这种组合策略可导致更有效地降低转移行为。似乎使用这种策略将带来更成功的治疗结果。